Biocartis Group NV provided earnings guidance for the year 2022. For the year, the company expects to Grow product revenue by 24-36% to between EUR 50 million and EUR 55 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.29 EUR | +1.05% | -.--% | -.--% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 29.58M | |
+73.25% | 12.38B | |
-20.57% | 7.81B | |
+6.54% | 6.72B | |
+12.78% | 5.39B | |
+38.73% | 5.03B | |
-16.79% | 4.72B | |
-22.01% | 4.06B | |
-30.14% | 2.68B | |
+52.38% | 2.59B |
- Stock Market
- Equities
- BCART Stock
- News Biocartis Group NV
- Biocartis Group NV Provides Earnings Guidance for the Year 2022